Neurolite

Chordate Medical enters agreement in Switzerland

Chordate Medical adds Switzerland as a new focus market for the Ozilia migraine treatment entering into a new partnership agreement with Neurolite, a well-established...
Elicera teams up with China Medical University for cancer study

Elicera teams up with China Medical University for cancer study

Elicera Therapeutics has announced a new research collaboration with the Fourth Affiliated Hospital of China Medical University to assess the efficacy of oncolytic virus...
Expres2ion to raise SEK 60 million

Rights issue takes Expres2ion breast cancer vaccine to phase I

Having validated its vaccine platform in Covid-19, Expres2ion Biotech now turns to the treatment of breast cancer. A SEK 60 million rights issue of...
BiBBInstruments teknologi uppmärksammas i medicinsk tidskrift

BiBBInstruments’ technology gets nod in medical journal

The interest in Swedish medtech BiBBInstruments’ biopsy instrument EndoDrill is increasing as doctors evaluate it in the clinic, being called a “game-changer” within endoscopic...
Kim_Baden_Kristensen_Brain+

BioStock Investor Pitch: Brain+

Brain+ is a health tech company focused on treatment and management of dementia. Centred around Cognitive Stimulation Therapy, the company's approach has the potential...
Biosergen towards first-in-patient trial with antifungal therapy

Biosergen towards first-in-patient trial with antifungal therapy

During Q1, Biosergen took major steps towards its goal to address the hidden threat of fungal infections. Not only was the company able to...
CLS

CLS’ partner initiates full market release in the US

CLS' commercial partner ClearPoint Neuro has initiated its full market release of the ClearPoint Prism 3T Neuro Laser Therapy System, which is based on...
Neolas vd: ”Certifikatet ett tydligt styrkebesked”

Neola’s CEO: “The certificate is a clear sign of strength”

Neola Medical's product Neola, developed for continuously monitoring premature infants' lungs, has been certified according to rigorous international standards. Thus, the company has passed...
Alligator’s mitazalimab data published in The Lancet Oncology

Alligator’s mitazalimab data published in The Lancet Oncology

Alligator Bioscience’s phase II data with cancer immunotherapy mitazalimab have been published in The Lancet Oncology – one of the most prestigious and internationally...
Cirasight works on the financing

Curasight committed to progressing pipeline

The partnership with Curium for diagnosis in prostate cancer is advancing and Curasight aims to accelerate the development of the therapeutic platform uTREAT in multiple...